Efficacy of Balloon-Expandable Stent Versus Self-Expandable Stent for the Atherosclerotic ILIAC Arterial Disease
NCT01834495 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230
Last updated 2019-08-14
Summary
The purpose of the investigators study is to examine and compare primary patency between balloon expandable cobalt chromium stent and self expandable nitinol stents (SCUBA versus COMPLETE-SE) in atherosclerotic iliac artery lesion.
Conditions
Interventions
- DEVICE
-
Balloon expandable stent
provisional stenting should be performed; the case that optimal ballooning response in not obtained should be enrolled. Optimal balloon response is defined as a residual pressure gradient of \> 15mmHg, residual stenosis of \>30% and flow limiting dissection
- DEVICE
-
Self expandable stent
provisional stenting should be performed; the case that optimal ballooning response in not obtained should be enrolled. Optimal balloon response is defined as a residual pressure gradient of \> 15mmHg, residual stenosis of \>30% and flow limiting dissection
Sponsors & Collaborators
-
Korea University Guro Hospital
lead OTHER
Principal Investigators
-
Seung Woon Rha, MD. PhD · Cardiovascular center, Korea University Guro Hospital, 80, Guro-dong, Guro-gu, Seoul, 152-703, Korea
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-28
- Primary Completion
- 2018-01-31
- Completion
- 2019-02-11
Countries
- South Korea
Study Locations
More Related Trials
-
Do Cobalt Chrome Stent and Paclitaxel-Eluting Stent Have Equivalent Clinical Result in Non-Complex Lesion?
NCT00852215 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease
NCT01653600 ·Status: UNKNOWN ·Phase: PHASE4
-
Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis
NCT04240444 ·Status: COMPLETED ·Phase: NA
-
Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)
NCT00231257 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety & Performance of the Xpert(TM) Stent in Treating Below-the-knee Lesions in Patients Undergoing Percutaneous Intervention for Chronic CLI.
NCT00515346 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions
NCT04744571 ·Status: UNKNOWN ·Phase: NA
-
Iliac Artery Treatment With The Invatec Scuba™ Cobalt Chromium Stent (INTENSE)
NCT00880230 ·Status: COMPLETED ·Phase: NA
-
Self-apposing Stentys Stents Registry
NCT02784405 ·Status: UNKNOWN
-
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.
NCT00233805 ·Status: COMPLETED ·Phase: PHASE2
-
Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis
NCT01967199 ·Status: TERMINATED ·Phase: PHASE4
-
Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac Artery
NCT00613418 ·Status: WITHDRAWN ·Phase: NA
-
Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients
NCT00462631 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of Drug Eluting Balloon and Drug Eluting Stent
NCT01539603 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)
NCT00233779 ·Status: COMPLETED ·Phase: PHASE2
-
Focal In-stent Restenosis After Drug-Eluting Stent
NCT00485004 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels
NCT06345209 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV)
NCT01186094 ·Status: COMPLETED ·Phase: PHASE4
-
The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study
NCT00753337 ·Status: COMPLETED ·Phase: NA
-
Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions
NCT05101005 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter
NCT03908450 ·Status: COMPLETED ·Phase: NA
-
Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction
NCT01489449 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction
NCT01347554 ·Status: COMPLETED ·Phase: PHASE4
-
Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery
NCT01396525 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up
NCT02785237 ·Status: COMPLETED ·Phase: NA